Several studies have shown that testing for high-risk human papillomavirus (HPV) types results in an improved sensitivity for CIN2+, compared with cytology, although with a somewhat lower specificity.

In human papillomavirus (HPV)-based screening, a repeat HPV test is often recommended for HPV-positive women with normal cytology (HPV-pos/cyt-neg), but its absolute risk of cervical precancer (CIN3+) ...

Please provide your email address to receive an email when new articles are posted on . HPV-based vs. cytology-based screening was tied to lower risks for invasive cervical cancer. Adverse events were ...

Background: Continued surveillance of human papillomavirus (HPV) vaccination is necessary to identify clinical benefits, particularly given the low rate of vaccine uptake and completion and ...

TUCSON, Ariz., June 16, 2015 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announced the publication of further results from the Primary ASC-US LSIL ...

Investigators examined cervical cancer screening guideline adherence among a nationally representative commercially insured cohort in the US to identify factors and modalities associated with ...

Human papillomavirus (HPV) testing was more sensitive than traditional Pap smears at detecting precancerous lesions of the cervix, a study in the June 7 issue of the Journal of the National Cancer ...

Jennifer E. Cameron, Anne F. Rositch, Nadja A. Vielot, Nelly R. Mugo, Jessie K.L. Kwatampora, Wairimu Waweru, Aubrey E. Gilliland, Michael E. Hagensee and Jennifer S ...

Gls-010, a novel anti-PD-1 mAb in Chinese patients with recurrent or metastatic cervical cancer: Results from a multicenter, open-label and single-arm phase II trial. This is an ASCO Meeting Abstract ...

Nov. 8, 2002 — Although the common teaching is that doctors should not use lubrication when obtaining specimens for cervical cytology, women have complained that the pain is significant. Two separate ...

Preoperative geriatric assessment (GA) and surgical outcomes in older women with gynecological (gyn) cancer. Validation of the predictive value of modeled HCG residual production “P” in low-risk ...